Skincare Surgipharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.50 M
as on 13-12-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 13-12-2024
- Revenue 4.70%
(FY 2022)
- Profit -14.27%
(FY 2022)
- Ebitda -2.66%
(FY 2022)
- Net Worth 21.36%
(FY 2022)
- Total Assets 47.24%
(FY 2022)
About Skincare Surgipharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.00 M.
Amritlal Malde, Jayesh Mehta, and Mehul Malde serve as directors at the Company.
- CIN/LLPIN
U33110MH1999PTC118396
- Company No.
118396
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Skincare Surgipharma Private Limited offer?
Skincare Surgipharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Pain Relief Drugs & Pharmaceuticals, Anesthetic, Industrial Chemicals & Supplies, Biocides, Medical & Surgical Clothing, OT Linen, Common Disease Medicines, Skin Ointment.
Who are the key members and board of directors at Skincare Surgipharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amritlal Malde  | Director | 17-Feb-1999 | Current |
| Jayesh Mehta | Director | 17-Feb-1999 | Current |
| Mehul Malde | Director | 16-Jan-2012 | Current |
Financial Performance and Corporate Structure Insights of Skincare Surgipharma.
Skincare Surgipharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.7% increase. The company also saw a substantial fall in profitability, with a 14.27% decrease in profit. The company's net worth Soared by an impressive increase of 21.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skincare Surgipharma?
In 2020, Skincare Surgipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nupinion Healthcare Private LimitedActive 37 years 6 monthsAmritlal Malde and Mehul Malde are mutual person
- Nupinion Labs Private LimitedActive 9 years 8 months
Amritlal Malde and Mehul Malde are mutual person
- The Pharmaceutical Wholesalers Association (Bombay)Active 28 years 6 months
Amritlal Malde is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 08 Sep 2023 | ₹4.00 M | Open |
Idbi Bank Limited Creation Date: 10 May 2014 | ₹1.00 M | Open |
How Many Employees Work at Skincare Surgipharma?
Unlock and access historical data on people associated with Skincare Surgipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skincare Surgipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skincare Surgipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
